4//SEC Filing
Vivo Opportunity Fund, L.P. 4
Accession 0001615774-18-006729
CIK 0001658247other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 4:50 PM ET
Size
37.4 KB
Accession
0001615774-18-006729
Insider Transaction Report
Form 4
Vivo Capital VIII, LLC
10% Owner
Transactions
- Purchase
Common Stock
2018-07-20$17.00/sh+141,177$2,400,009→ 141,177 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2018-07-20−8,424,416→ 0 total(indirect: See Footnote)→ Common Stock (2,560,613 underlying) - Conversion
Series B Preferred Stock
2018-07-20−1,358,903→ 0 total(indirect: See Footnote)→ Common Stock (413,040 underlying) - Conversion
Common Stock
2018-07-20+353,590→ 353,590 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$17.00/sh+7,137$121,329→ 417,762 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$20.73/sh+153,180$3,175,421→ 294,357 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2018-07-20−1,163,311→ 0 total(indirect: See Footnote)→ Common Stock (353,590 underlying) - Conversion
Common Stock
2018-07-20+2,560,613→ 2,560,613 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-20+413,040→ 2,973,653 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-20+57,035→ 410,625 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$17.00/sh+51,686$878,662→ 3,025,339 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2018-07-20−187,648→ 0 total(indirect: See Footnote)→ Common Stock (57,035 underlying)
Vivo Capital, LLC
10% Owner
Transactions
- Purchase
Common Stock
2018-07-20$17.00/sh+51,686$878,662→ 3,025,339 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$20.73/sh+153,180$3,175,421→ 294,357 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2018-07-20−8,424,416→ 0 total(indirect: See Footnote)→ Common Stock (2,560,613 underlying) - Conversion
Series A Preferred Stock
2018-07-20−1,163,311→ 0 total(indirect: See Footnote)→ Common Stock (353,590 underlying) - Conversion
Series B Preferred Stock
2018-07-20−1,358,903→ 0 total(indirect: See Footnote)→ Common Stock (413,040 underlying) - Conversion
Common Stock
2018-07-20+2,560,613→ 2,560,613 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-20+353,590→ 353,590 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-20+57,035→ 410,625 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-20+413,040→ 2,973,653 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$17.00/sh+7,137$121,329→ 417,762 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$17.00/sh+141,177$2,400,009→ 141,177 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2018-07-20−187,648→ 0 total(indirect: See Footnote)→ Common Stock (57,035 underlying)
Vivo Capital Fund VIII, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2018-07-20$17.00/sh+7,137$121,329→ 417,762 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$17.00/sh+141,177$2,400,009→ 141,177 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$20.73/sh+153,180$3,175,421→ 294,357 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2018-07-20−8,424,416→ 0 total(indirect: See Footnote)→ Common Stock (2,560,613 underlying) - Conversion
Series B Preferred Stock
2018-07-20−1,358,903→ 0 total(indirect: See Footnote)→ Common Stock (413,040 underlying) - Conversion
Common Stock
2018-07-20+2,560,613→ 2,560,613 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-20+353,590→ 353,590 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-20+413,040→ 2,973,653 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-20+57,035→ 410,625 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$17.00/sh+51,686$878,662→ 3,025,339 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2018-07-20−187,648→ 0 total(indirect: See Footnote)→ Common Stock (57,035 underlying) - Conversion
Series A Preferred Stock
2018-07-20−1,163,311→ 0 total(indirect: See Footnote)→ Common Stock (353,590 underlying)
Vivo Capital Surplus Fund VIII, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2018-07-20+353,590→ 353,590 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-20+57,035→ 410,625 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2018-07-20−1,358,903→ 0 total(indirect: See Footnote)→ Common Stock (413,040 underlying) - Conversion
Series B Preferred Stock
2018-07-20−187,648→ 0 total(indirect: See Footnote)→ Common Stock (57,035 underlying) - Conversion
Common Stock
2018-07-20+2,560,613→ 2,560,613 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-20+413,040→ 2,973,653 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$17.00/sh+7,137$121,329→ 417,762 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$17.00/sh+51,686$878,662→ 3,025,339 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$17.00/sh+141,177$2,400,009→ 141,177 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2018-07-20−1,163,311→ 0 total(indirect: See Footnote)→ Common Stock (353,590 underlying) - Purchase
Common Stock
2018-07-20$20.73/sh+153,180$3,175,421→ 294,357 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2018-07-20−8,424,416→ 0 total(indirect: See Footnote)→ Common Stock (2,560,613 underlying)
Vivo Opportunity, LLC
10% Owner
Transactions
- Conversion
Common Stock
2018-07-20+2,560,613→ 2,560,613 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$17.00/sh+141,177$2,400,009→ 141,177 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2018-07-20−8,424,416→ 0 total(indirect: See Footnote)→ Common Stock (2,560,613 underlying) - Conversion
Series A Preferred Stock
2018-07-20−1,163,311→ 0 total(indirect: See Footnote)→ Common Stock (353,590 underlying) - Purchase
Common Stock
2018-07-20$17.00/sh+51,686$878,662→ 3,025,339 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$20.73/sh+153,180$3,175,421→ 294,357 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2018-07-20−1,358,903→ 0 total(indirect: See Footnote)→ Common Stock (413,040 underlying) - Conversion
Common Stock
2018-07-20+353,590→ 353,590 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-20+413,040→ 2,973,653 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-20+57,035→ 410,625 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$17.00/sh+7,137$121,329→ 417,762 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2018-07-20−187,648→ 0 total(indirect: See Footnote)→ Common Stock (57,035 underlying)
Vivo Opportunity Fund, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2018-07-20+2,560,613→ 2,560,613 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-20+353,590→ 353,590 total(indirect: See Footnote) - Conversion
Common Stock
2018-07-20+57,035→ 410,625 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$17.00/sh+51,686$878,662→ 3,025,339 total(indirect: See Footnote) - Conversion
Series B Preferred Stock
2018-07-20−1,358,903→ 0 total(indirect: See Footnote)→ Common Stock (413,040 underlying) - Conversion
Common Stock
2018-07-20+413,040→ 2,973,653 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$17.00/sh+7,137$121,329→ 417,762 total(indirect: See Footnote) - Purchase
Common Stock
2018-07-20$20.73/sh+153,180$3,175,421→ 294,357 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2018-07-20−8,424,416→ 0 total(indirect: See Footnote)→ Common Stock (2,560,613 underlying) - Purchase
Common Stock
2018-07-20$17.00/sh+141,177$2,400,009→ 141,177 total(indirect: See Footnote) - Conversion
Series A Preferred Stock
2018-07-20−1,163,311→ 0 total(indirect: See Footnote)→ Common Stock (353,590 underlying) - Conversion
Series B Preferred Stock
2018-07-20−187,648→ 0 total(indirect: See Footnote)→ Common Stock (57,035 underlying)
Footnotes (7)
- [F1]The shares of the Issuer's Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, at a ratio of 3.29 to 1 share, immediately prior to the consummation of the Issuer's initial public offering. The Series A Preferred Stock and Series B Preferred Stock had no expiration date.
- [F2]These securities are held of record by Vivo Capital Fund VIII, L.P. ("VCF").
- [F3]These securities are held of record by Vivo Capital Surplus Fund VIII, L.P. ("VCSF").
- [F4]These securities are held of record by Vivo Opportunity Fund, L.P. ("VOF").
- [F5]Vivo Capital VIII, LLC ("Vivo LLC") is the general partner of VCF and VCSF. Vivo Capital LLC is the management company of Vivo LLC. The voting members of each of Vivo Capital LLC and Vivo LLC are Frank Kung, Albert Cha, Edgar Engleman, Chen Yu and Shan Fu, none of whom has individual voting or investment power with respect to these securities. Jack B. Nielsen, M.Sc., a director of the Issuer, is a Managing Director at Vivo Capital LLC. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes.
- [F6]Vivo Opportunity, LLC is the general partner of VOF. Vivo Capital LLC is the management company of Vivo Opportunity, LLC. The voting members of Vivo Opportunity, LLC are Frank Kung, Albert Cha, Shan Fu, Gaurav Aggarwal and Michael Chang, none of whom has individual voting or investment power with respect to these securities. Each of the above-listed individuals disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purposes of Section 16 or for any other purposes.
- [F7]The price reported herein is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.25 to $24.5, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (7) to this Form 4.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001726403
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 4:50 PM ET
- Size
- 37.4 KB